Variant report
Variant | esv3433335 |
---|---|
Chromosome Location | chr6:161088362-161091560 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:211)
- CpG islands (count:61)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161088755-161088805 | NH-A | brain: | n/a |
2 | chr6:161088755-161088805 | ProgFib | skin: | n/a |
3 | chr6:161088755-161088805 | K562 | blood: | n/a |
4 | chr6:161088755-161088805 | Hela-S3 | cervix: | n/a |
5 | chr6:161088755-161088805 | AG09319 | gingival: | n/a |
6 | chr6:161088755-161088805 | HCT-116 | colon: | n/a |
7 | chr6:161088755-161088805 | H1-hESC | embryonic stem cell: | embryo |
8 | chr6:161088755-161088805 | SK-N-SH | brain: | n/a |
9 | chr6:161088755-161088805 | IMR90 | lung: | fetal |
10 | chr6:161088755-161088805 | BJ | skin: | n/a |
11 | chr6:161088755-161088805 | SK-N-SH_RA | brain: | n/a |
12 | chr6:161088755-161088805 | Jurkat | blood: | n/a |
13 | chr6:161088755-161088805 | AG04450 | lung: | fetal |
14 | chr6:161088755-161088805 | HepG2 | liver: | n/a |
15 | chr6:161088755-161088805 | HCPEpiC | choroid plexus: | n/a |
16 | chr6:161088755-161088805 | Hepatocyte | liver: | n/a |
17 | chr6:161088755-161088805 | HRCEpiC | kidney: | n/a |
18 | chr6:161088755-161088805 | T-47D | breast: | n/a |
19 | chr6:161088755-161088805 | RPTEC | kidney: | n/a |
20 | chr6:161088755-161088805 | LNCaP | prostate: | n/a |
21 | chr6:161088755-161088805 | AG04449 | skin: | fetal |
22 | chr6:161088755-161088805 | PrEC | prostate: | n/a |
23 | chr6:161088755-161088805 | GM12892 | blood: | n/a |
24 | chr6:161088755-161088805 | CMK | blood: | n/a |
25 | chr6:161088755-161088805 | AG10803 | skin: | n/a |
26 | chr6:161088755-161088805 | MCF-7 | breast: | n/a |
27 | chr6:161088755-161088805 | GM12891 | blood: | n/a |
28 | chr6:161088755-161088805 | HIPEpiC | eye: | n/a |
29 | chr6:161088755-161088805 | HCF | heart: | n/a |
30 | chr6:161088755-161088805 | HMEC | breast: | n/a |
31 | chr6:161088755-161088805 | SKMC | muscle: | n/a |
32 | chr6:161088755-161088805 | U87 | brain: | n/a |
33 | chr6:161088755-161088805 | Caco-2 | colon: | n/a |
34 | chr6:161088755-161088805 | AG09309 | skin: | n/a |
35 | chr6:161088755-161088805 | ovcar-3 | ovarian: | n/a |
36 | chr6:161088755-161088805 | HL-60 | blood: | n/a |
37 | chr6:161088755-161088805 | PFSK-1 | brain: | n/a |
38 | chr6:161088755-161088805 | BE2_C | brain: | n/a |
39 | chr6:161088755-161088805 | HCM | heart: | n/a |
40 | chr6:161088755-161088805 | SAEC | small airway: | n/a |
41 | chr6:161088755-161088805 | MCF10A-Er-Src | breast: | n/a |
42 | chr6:161088755-161088805 | HPAEpiC | pulmonary alveolar: | n/a |
43 | chr6:161088755-161088805 | NB4 | blood: | n/a |
44 | chr6:161088755-161088805 | NHDF-neo | bronchial: | n/a |
45 | chr6:161088755-161088805 | HRE | kidney: | n/a |
46 | chr6:161088755-161088805 | GM06990 | blood: | n/a |
47 | chr6:161088755-161088805 | SK-N-MC | brain: | n/a |
48 | chr6:161088755-161088805 | ECC-1 | luminal epithelium: | n/a |
49 | chr6:161088755-161088805 | GM19239 | blood: | n/a |
50 | chr6:161088755-161088805 | HNPCEpiC | eye: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161080728..161083245-chr6:161087740..161089889,2 | MCF-7 | breast: | |
2 | chr6:160954972..160955719-chr6:161088699..161089595,2 | MCF-7 | breast: | |
3 | chr6:160941041..160942817-chr6:161087432..161089515,2 | K562 | blood: | |
4 | chr6:160876729..160877411-chr6:161088842..161089583,2 | K562 | blood: | |
5 | chr6:160939583..160942817-chr6:161087432..161090286,3 | K562 | blood: | |
6 | chr6:160940535..160941592-chr6:161088101..161089900,7 | K562 | blood: | |
7 | chr6:160876814..160877519-chr6:161088556..161089198,2 | MCF-7 | breast: | |
8 | chr6:160940670..160941542-chr6:161088487..161089076,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LPA | TF binding region |
LPA | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17557261 | chr6:161088399-161088400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540041615 | chr6:161088400-161088401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147603287 | chr6:161088411-161088412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115227831 | chr6:161088417-161088418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs113585105 | chr6:161088422-161088423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183904052 | chr6:161088539-161088540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189242308 | chr6:161088545-161088546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561443884 | chr6:161088548-161088549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs555629057 | chr6:161088617-161088618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76214705 | chr6:161088643-161088644 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs534675790 | chr6:161088684-161088685 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs142210658 | chr6:161088707-161088708 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs578008201 | chr6:161088727-161088728 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs544578826 | chr6:161088756-161088757 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs545983399 | chr6:161088836-161088837 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs562589559 | chr6:161088858-161088859 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs783149 | chr6:161088918-161088919 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs75274517 | chr6:161088956-161088957 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs573301366 | chr6:161088982-161088983 | Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs114064806 | chr6:161089018-161089019 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs546821711 | chr6:161089024-161089025 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs527308229 | chr6:161089054-161089055 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs193080275 | chr6:161089077-161089078 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs184616879 | chr6:161089108-161089109 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs564219274 | chr6:161089129-161089130 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs532840008 | chr6:161089160-161089161 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs186579892 | chr6:161089228-161089229 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs569952651 | chr6:161089236-161089237 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs113708485 | chr6:161089237-161089238 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs535636451 | chr6:161089284-161089285 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs56393506 | chr6:161089307-161089308 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs566004217 | chr6:161089329-161089330 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs191761201 | chr6:161089340-161089341 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs115924742 | chr6:161089393-161089394 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs548853544 | chr6:161089394-161089395 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs151228674 | chr6:161089444-161089445 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs117830977 | chr6:161089465-161089466 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs576334565 | chr6:161089474-161089475 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs116252530 | chr6:161089508-161089509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561982209 | chr6:161089526-161089527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572332321 | chr6:161089535-161089536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541023010 | chr6:161089552-161089553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372391993 | chr6:161089573-161089574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563970515 | chr6:161089576-161089577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs377558433 | chr6:161089578-161089579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532930193 | chr6:161089621-161089622 | ZNF genes & repeats Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs140403723 | chr6:161089644-161089645 | ZNF genes & repeats Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs74658762 | chr6:161089710-161089711 | ZNF genes & repeats Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs529466025 | chr6:161089711-161089712 | ZNF genes & repeats Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs374625227 | chr6:161089742-161089743 | ZNF genes & repeats Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chordoma | 18071362 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161084200-161089800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr6:161087200-161088600 | Weak transcription | Liver | Liver |
3 | chr6:161087400-161089600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
4 | chr6:161087600-161100200 | Weak transcription | Right Atrium | heart |
5 | chr6:161088600-161089400 | Enhancers | Liver | Liver |
6 | chr6:161088800-161089000 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
7 | chr6:161088800-161089000 | Flanking Bivalent TSS/Enh | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:161088800-161089000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
9 | chr6:161089400-161089800 | Weak transcription | Liver | Liver |
10 | chr6:161089600-161090000 | ZNF genes & repeats | H9 Cell Line | embryonic stem cell |
11 | chr6:161089600-161090200 | ZNF genes & repeats | Fetal Adrenal Gland | Adrenal Gland |
12 | chr6:161089800-161090200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr6:161089800-161090200 | Bivalent/Poised TSS | Breast Myoepithelial Primary Cells | Breast |
14 | chr6:161089800-161090200 | Active TSS | Fetal Kidney | kidney |
15 | chr6:161089800-161091000 | Strong transcription | Liver | Liver |
16 | chr6:161090200-161090800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
17 | chr6:161090800-161091400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
18 | chr6:161091000-161098200 | Weak transcription | Liver | Liver |
19 | chr6:161091400-161092200 | Flanking Active TSS | Fetal Adrenal Gland | Adrenal Gland |